Novavax Covid shot 90 percent efficacious; Google Workspace for everyone; and Harsha Moily's journey from micro-finance to clean tech VC

Novavax said yesterday that its recombinant nanoparticle protein-based Covid 19 vaccine, demonstrated 100 percent protection against moderate and severe disease and 90.4 percent efficacy overall, after Phase 3 trials. Also in this programme, Google has made its Workspace open to anyone with an account; and later, entrepreneur Harsha Moily talks about his new VC firm, and plans to invest $200 million in clean tech startups in India and Israel